Medical Science, Medical Affairs, Astellas Pharma Inc, Tokyo.
Department of Internal Medicine, Division of Gastroenterology, Hyogo College of Medicine, Hyogo, Japan.
J Clin Gastroenterol. 2022 Jan 1;56(1):e64-e70. doi: 10.1097/MCG.0000000000001473.
This survey aims to determine relevant patient characteristics, treatment satisfaction, and bothersome symptoms in Japanese patients with chronic constipation (CC) treated at medical institutions.
Epidemiological surveys of Japanese patients with CC are limited.
This internet survey, conducted in 2017, included 500 adults (selected from 589 respondents to match age composition ratio in Japan) who experienced constipation-like symptoms for ≥6 months, were treated at medical institutions for symptoms, and were taking any prescribed medication.
Of 500 patients, 65.6% were female and 62.6% had experienced constipation for >10 years. Abdominal bloating, infrequent bowel movement, hard consistency of stool, and difficulty of defecation were the most frequently reported and most bothersome symptoms in males and females. Overall, 29% of patients were satisfied with treatment (36% of males, 26% of females); the individual major CC symptom with the highest level of treatment satisfaction was infrequent bowel movement (31% of total, 45% of males, 26% of females). The level of treatment satisfaction for most individual major CC symptoms was lower in females than in males, and overall treatment satisfaction by therapeutic categories ranged from 16% to 46%. Mean overall treatment satisfaction, as well as mean treatment satisfaction for each major symptom, decreased with increasing number of treatments.
The survey results suggest that conventional treatment options were not effective enough to improve bothersome symptoms or treatment satisfaction. Treatment selection that is tailored to individual symptoms and takes patient characteristics into consideration may be key to improving patients' treatment satisfaction.
本调查旨在确定在医疗机构接受治疗的日本慢性便秘(CC)患者的相关患者特征、治疗满意度和困扰症状。
日本 CC 患者的流行病学调查有限。
这项于 2017 年进行的互联网调查包括 500 名成年人(从 589 名应答者中选择,以匹配日本的年龄构成比例),他们经历了≥6 个月的类似便秘症状,在医疗机构因症状接受治疗,并正在服用任何规定的药物。
在 500 名患者中,65.6%为女性,62.6%的便秘病史超过 10 年。腹胀、排便次数减少、粪便硬度和排便困难是男性和女性报告最多且最困扰的症状。总体而言,29%的患者对治疗满意(男性 36%,女性 26%);治疗满意度最高的单个主要 CC 症状是排便次数减少(占总数的 31%,男性占 45%,女性占 26%)。女性对大多数单个主要 CC 症状的治疗满意度低于男性,且按治疗类别划分的总体治疗满意度范围为 16%至 46%。总体治疗满意度以及每个主要症状的治疗满意度均随治疗次数的增加而降低。
调查结果表明,常规治疗方案不足以改善困扰症状或治疗满意度。针对个体症状选择治疗方案并考虑患者特征可能是提高患者治疗满意度的关键。